Citius Pharmaceuticals, Inc. (CTXR)
USD 2.59
(-5.13%)
USD 2.59
(-5.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 103.61 Million | 113.99 Million | 142.42 Million | 43.77 Million | 28.98 Million | 31.05 Million |
| Total Current Assets | 34.37 Million | 44.56 Million | 72.81 Million | 13.98 Million | 7.94 Million | 10.06 Million |
| Cash And Short Term Investments | 26.48 Million | 41.71 Million | 70.07 Million | 13.85 Million | 7.89 Million | 9.18 Million |
| Cash and Cash Equivalents | 26.48 Million | 41.71 Million | 70.07 Million | 13.85 Million | 7.89 Million | 9.18 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | 818.34 Thousand |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | 7.88 Million | 2.85 Million | 2.74 Million | 122.23 Thousand | 48.11 Thousand | 57.73 Thousand |
| Total Non-Current Assets | 69.24 Million | 69.43 Million | 69.61 Million | 29.79 Million | 21.04 Million | 20.99 Million |
| Net PPE | 455.85 Thousand | 650.17 Thousand | 829.85 Thousand | 987.78 Thousand | 590.00 | 1483.00 |
| Good Will And Intangible Assets | 68.74 Million | 68.74 Million | 68.74 Million | 28.74 Million | 20.98 Million | 20.98 Million |
| Good Will | 9.34 Million | 9.34 Million | 9.34 Million | 9.34 Million | 1.58 Million | 1.58 Million |
| Intangible Assets | 59.4 Million | 59.4 Million | 59.4 Million | 19.4 Million | 19.4 Million | 19.4 Million |
| Long-Term Investments | - | - | 29.17 Million | 16.92 Million | - | - |
| Tax Assets | -44.91 Million | -39.93 Million | -29.17 Million | -16.92 Million | - | - |
| Other Non Current Assets | 44.95 Million | 39.96 Million | 38.06 Thousand | 57.09 Thousand | 57.09 Thousand | 2167.00 |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 12.17 Million | 10.57 Million | 9.64 Million | 10.1 Million | 4.6 Million | 3.18 Million |
| Total Current Liabilities | 5.77 Million | 4.53 Million | 3.98 Million | 4.09 Million | 4.6 Million | 3.18 Million |
| Account Payables | 2.92 Million | 1.16 Million | 1.27 Million | 1.85 Million | 2.71 Million | 1.57 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 218.38 Thousand | 196.98 Thousand | 177.23 Thousand | 331.96 Thousand | 172.97 Thousand | 172.97 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 2.63 Million | 3.16 Million | 2.52 Million | 1.9 Million | 1.72 Million | 1.43 Million |
| Total Non Current Liabilities | 6.4 Million | 6.04 Million | 5.66 Million | 6 Million | 4.98 Million | 1.74 Million |
| Long-Term Debt | 262.86 Thousand | 481.24 Thousand | 678.23 Thousand | 1.02 Million | - | - |
| Deferred Revenue Non Current | -6137.80 | -5561.80 | -4985.80 | 164.58 | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 6137.80 | 5561.80 | 4985.80 | -164.58 | - | - |
| Other Liabilities | - | - | - | - | -4.98 Million | -1.74 Million |
| Total Equity | 91.43 Million | 103.42 Million | 132.78 Million | 33.67 Million | 24.37 Million | 27.86 Million |
| Stock Holders Equity | 90.83 Million | 102.82 Million | 132.18 Million | 33.67 Million | 24.37 Million | 27.86 Million |
| Common Stock | 158.85 Thousand | 146.21 Thousand | 145.97 Thousand | 55.57 Thousand | 28.93 Thousand | 16.19 Thousand |
| Retained Earnings | -162.23 Million | -129.68 Million | -96.04 Million | -70.59 Million | -55.81 Million | -40.25 Million |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | 90.83 Million | 102.82 Million | 132.18 Million | 33.67 Million | 24.37 Million | 27.86 Million |
| Capital Lease Obligation | 481.24 Thousand | 678.23 Thousand | 855.47 Thousand | 1.01 Million | - | - |
| Total Investments | - | - | 29.17 Million | 16.92 Million | - | - |
| Total Debt | 481.24 Thousand | 678.23 Thousand | 855.47 Thousand | 1.35 Million | 172.97 Thousand | 172.97 Thousand |
| Net Debt | -25.99 Million | -41.03 Million | -69.21 Million | -12.5 Million | -7.72 Million | -9.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | 97.09 Million | 90.71 Million | 97.39 Million | 103.61 Million | 103.61 Million | 110.4 Million |
| Total Current Assets | 28 Million | 21.57 Million | 28.21 Million | 34.37 Million | 34.37 Million | 41.11 Million |
| Cash And Short Term Investments | 17.91 Million | 12.55 Million | 20.34 Million | 26.48 Million | 26.48 Million | 33.28 Million |
| Cash and Cash Equivalents | 17.91 Million | 12.55 Million | 20.34 Million | 26.48 Million | 26.48 Million | 33.28 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | 10.09 Million | 9.01 Million | 7.86 Million | 7.88 Million | 7.88 Million | 7.83 Million |
| Total Non-Current Assets | 69.08 Million | 69.13 Million | 69.18 Million | 69.24 Million | 69.24 Million | 69.29 Million |
| Net PPE | 299.93 Thousand | 352.78 Thousand | 404.85 Thousand | 455.85 Thousand | 455.85 Thousand | 505.82 Thousand |
| Good Will And Intangible Assets | 68.74 Million | 68.74 Million | 68.74 Million | 68.74 Million | 68.74 Million | 68.74 Million |
| Good Will | 9.34 Million | 9.34 Million | 9.34 Million | 9.34 Million | 9.34 Million | 9.34 Million |
| Intangible Assets | 59.4 Million | 59.4 Million | 59.4 Million | 59.4 Million | 59.4 Million | 59.4 Million |
| Long-Term Investments | - | - | - | 44.91 Million | - | - |
| Tax Assets | - | - | - | -44.91 Million | -44.91 Million | - |
| Other Non Current Assets | 38.06 Thousand | 38.06 Thousand | 38.06 Thousand | 38.06 Thousand | 44.95 Million | 38.06 Thousand |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 10.8 Million | 10.74 Million | 12.06 Million | 12.17 Million | 12.17 Million | 12.1 Million |
| Total Current Liabilities | 4.15 Million | 4.17 Million | 5.57 Million | 5.77 Million | 5.77 Million | 5.79 Million |
| Account Payables | 1.66 Million | 2.66 Million | 2.64 Million | 2.92 Million | 2.92 Million | 3.07 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 235.58 Thousand | 229.73 Thousand | 224 Thousand | 218.38 Thousand | 218.38 Thousand | 212.87 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 2.25 Million | 1.27 Million | 2.7 Million | 2.63 Million | 2.63 Million | 2.49 Million |
| Total Non Current Liabilities | 6.65 Million | 6.57 Million | 6.48 Million | 6.4 Million | 6.4 Million | 6.31 Million |
| Long-Term Debt | 84.43 Thousand | 145.09 Thousand | 204.56 Thousand | 262.86 Thousand | 262.86 Thousand | 320.01 Thousand |
| Deferred Revenue Non Current | -6.56 Million | -6.42 Million | -6281.80 | -6137.80 | -6137.80 | -5993.80 |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 6.56 Million | 6.42 Million | 6281.80 | 6137.80 | 6137.80 | 5993.80 |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 86.28 Million | 79.96 Million | 85.33 Million | 91.43 Million | 91.43 Million | 98.3 Million |
| Stock Holders Equity | 85.68 Million | 79.36 Million | 84.73 Million | 90.83 Million | 90.83 Million | 97.69 Million |
| Common Stock | 180.72 Thousand | 159.09 Thousand | 158.96 Thousand | 158.85 Thousand | 158.85 Thousand | 158.85 Thousand |
| Retained Earnings | -190.58 Million | -180 Million | -171.46 Million | -162.23 Million | -162.23 Million | -152.28 Million |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | 85.68 Million | 79.36 Million | 84.73 Million | 90.83 Million | 90.83 Million | 97.69 Million |
| Capital Lease Obligation | 84.43 Thousand | 145.09 Thousand | 428.56 Thousand | 481.24 Thousand | 481.24 Thousand | 532.88 Thousand |
| Total Investments | - | - | - | 44.91 Million | - | - |
| Total Debt | 320.01 Thousand | 374.83 Thousand | 428.56 Thousand | 481.24 Thousand | 481.24 Thousand | 532.88 Thousand |
| Net Debt | -17.59 Million | -12.18 Million | -19.91 Million | -25.99 Million | -25.99 Million | -32.74 Million |
DUERF
OKEPF
NOVO-B
9830
603341
5112